antibiotics
Emblaveo, developed by Pfizer and approved today by the European Commission, can be used to treat complicated intra-abdominal and urinary tract infections, hospital-acquired pneumonia and infections caused by certain types of drug-resistant bacteria. “This newly approved medicine will fill an important gap where there are currently a very limited number of treatment options,” said the EU executive in a press release. This authorisation comes a month after the European Medicines Agency adopted a positive opinion and recommended its marketing authorisation. The antibiotic was evaluated under EMA...
Euronews (English)
Researchers in the United States have created a new antibiotic that they say overcomes diverse forms of antimicrobial resistance. The synthetic antibiotic, called cresomycin, was effective against multidrug-resistant strains of bacteria like Staphylococcus aureus, Escherichia coli, and Pseudomonas aeruginosa. Two of these bacteria are included on the World Health Organization (WHO)’s list of priority pathogens for which new antibiotics are “urgently needed”. Antimicrobial resistance, when bacteria, viruses, or other microbes no longer respond to medicine, is a top public health threat that cau...
Euronews (English)
Washington (AFP) - Amid soaring rates of chlamydia, gonorrhea and syphilis, US health authorities on Monday proposed that doctors begin prescribing a common antibiotic as a pill taken after sex, despite concerns over fueling more resistant strains. DoxyPEP, or doxycycline used as a post-exposure prophylaxis, was found to cut the risk of developing these infections in clinical trials involving men who have sex with men and transgender women who engaged in condomless sex. Draft guidelines developed by the Centers for Disease Control and Prevention (CDC) accordingly target only these higher risk ...
AFP
閲覧を続けるには、ノアドット株式会社が「プライバシーポリシー」に定める「アクセスデータ」を取得することを含む「nor.利用規約」に同意する必要があります。
「これは何?」という方はこちら